MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$113,671K
Cash and cash
equivalents
$49,860K
Prepaid expenses and
other current assets
$5,900K
Total current assets
$169,431K
Other non-current
assets
$4,240K
Operating right-of-use
assets
$939K
Property and equipment,
net
$648K
Total assets
$175,258K
Accumulated deficit
-$204,545K
Accumulated other
comprehensive (loss) income
-$439K
Total liabilities,
convertible preference...
$175,258K
Total stockholders'
deficit
-$198,618K
Additional paid in capital
$6,366K
Preferred stock
value-Series CConvertible...
$156,421K
Preferred stock
value-Series BConvertible...
$134,975K
Preferred stock
value-Series AConvertible...
$63,536K
Total liabilities
$13,708K
Preferred stock
value-Series Seed...
$5,236K
Total current
liabilities
$13,189K
Operating lease
liabilities, net of current...
$519K
Accrued expenses and
other current...
$6,963K
Accounts payable
$5,682K
Operating lease
liabilities
$544K
Back
Back
Balance Sheet
Hemab Therapeutics Holdings, Inc. (COAG)
Hemab Therapeutics Holdings, Inc. (COAG)
source: myfinsight.com